Adaro, April .
HRN: 25-99-67 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/18/2024
CEFUROXIME 1.5GM (VIAL)
10/18/2024
10/19/2024
IV
1.5g
Q8hrs
S/P LSTCS With IUD
Waiting Final Action
Indication: Prophylaxis Type of Infection: Reproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes